ATE165733T1 - Wasser-in-oel-lotion, die ein corticosteroid enthaelt - Google Patents

Wasser-in-oel-lotion, die ein corticosteroid enthaelt

Info

Publication number
ATE165733T1
ATE165733T1 AT95904527T AT95904527T ATE165733T1 AT E165733 T1 ATE165733 T1 AT E165733T1 AT 95904527 T AT95904527 T AT 95904527T AT 95904527 T AT95904527 T AT 95904527T AT E165733 T1 ATE165733 T1 AT E165733T1
Authority
AT
Austria
Prior art keywords
water
pct
corticosteroid
lotion containing
oil
Prior art date
Application number
AT95904527T
Other languages
English (en)
Inventor
Henning Sattler
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934344697 external-priority patent/DE4344697A1/de
Application filed by Galderma Sa filed Critical Galderma Sa
Application granted granted Critical
Publication of ATE165733T1 publication Critical patent/ATE165733T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT95904527T 1993-12-27 1994-12-22 Wasser-in-oel-lotion, die ein corticosteroid enthaelt ATE165733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934344697 DE4344697A1 (de) 1993-12-27 1993-12-27 Corticosteroide enthaltende W/O-Lotion

Publications (1)

Publication Number Publication Date
ATE165733T1 true ATE165733T1 (de) 1998-05-15

Family

ID=6506382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904527T ATE165733T1 (de) 1993-12-27 1994-12-22 Wasser-in-oel-lotion, die ein corticosteroid enthaelt

Country Status (6)

Country Link
US (1) US5653989A (de)
EP (1) EP0737062B1 (de)
JP (1) JP3731607B2 (de)
AT (1) ATE165733T1 (de)
DE (2) DE4345186C2 (de)
WO (1) WO1995017883A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643238A1 (de) * 1996-10-19 1998-04-23 Beiersdorf Ag Antitranspirant- und Deodorantstifte mit hohem Wassergehalt
US5869075A (en) * 1997-08-15 1999-02-09 Kimberly-Clark Worldwide, Inc. Soft tissue achieved by applying a solid hydrophilic lotion
US6630152B2 (en) * 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
DE10048125A1 (de) * 2000-09-28 2002-04-18 Beiersdorf Ag Zubereitungen von Emulsionstyp W/O mit erhöhtem Wassergehalt, mit mittelpolaren und/oder unpolaren Lipiden und einem oder mehreren grenzflächenaktiven Polyethern vom Typ A-O-B-O-A
DE10048429A1 (de) * 2000-09-29 2002-04-11 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, mit mittelpolaren und/oder unpolaren Lipiden und einem oder mehreren grenzflächenaktiven Polyethern von Typ A-O-B-O-A sowie einer Substanz gewählt aus der Gruppe der nichtionischen Polymere
DE10048366A1 (de) 2000-09-29 2002-04-11 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, mit mittelpolaren und/oder unpolaren Lipiden und einem oder mehreren grenzflächenaktiven Polyethern vom Typ A-O-B-O-A sowie mit mindestens einer Substanz, gewählt aus der Gruppe der kationischen Polymere
DE10048427A1 (de) * 2000-09-29 2002-04-11 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, mit mittelpolaren und/oder unpolaren Lipiden und einem oder mehreren grenzflächenaktiven Polyet hern vom Typ A-O-B-O-A sowie mindestens einer Substanz gewählt aus der Gruppe der anionischen und oder amphoteren Polymere
DE10049056A1 (de) * 2000-10-04 2002-04-11 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt enthaltend Polyetherpolester sowie mindestens einer Substanz gewählt aus der Gruppe der anionischen und/oder amphoteren Polymere
JP2002265347A (ja) * 2001-03-13 2002-09-18 Shiseido Co Ltd コーニファイドエンベロープの成熟を促す化粧料
AUPS158502A0 (en) * 2002-04-08 2002-05-16 Dermcare-Vet Pty Ltd Allergic dermatitis composition and method of treatment
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
WO2005089317A2 (en) * 2004-03-15 2005-09-29 3M Innovative Properties Company Immune response modifier formulations and methods
SG151333A1 (en) 2004-04-01 2009-04-30 Univ Nanyang Addressable chem/bio chip array
DE102006053360A1 (de) * 2006-11-10 2008-05-15 Evonik Stockhausen Gmbh Hautreinigungsmittel, insbesondere Kälteschutzcreme
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US20120015048A1 (en) * 2010-07-08 2012-01-19 Prithwiraj Maitra Skin care emulsion composition
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US9205093B2 (en) * 2012-09-11 2015-12-08 Gary Marder Hydrocortisone nanotechnological delivery system
FR3039399B1 (fr) * 2015-07-31 2018-08-24 Idl International Drug Licensing Creme pour l'admnistration de steroides et son procede de preparation
CA3024205A1 (en) * 2016-05-16 2017-11-23 Delivra Inc. Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826257C3 (de) * 1978-06-15 1980-12-04 Beiersdorf Ag, 2000 Hamburg Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt
US4252796A (en) * 1979-08-17 1981-02-24 Yu Ruey J Stable water-in-oil emulsions
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS58162516A (ja) * 1982-03-20 1983-09-27 Fujisawa Pharmaceut Co Ltd ステロイド含有油中水型乳剤
US4464389A (en) * 1982-10-20 1984-08-07 Sri International Esters of retinoic acid and pentaerythritol and monobenzal acetals thereof
JPS6272611A (ja) * 1985-09-27 1987-04-03 Kao Corp 皮膚外用剤
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
GB8821129D0 (en) * 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
US5196448A (en) * 1991-01-22 1993-03-23 Stiefel Laboratories, Inc. Antiinflammatory compositions and method of use

Also Published As

Publication number Publication date
EP0737062A1 (de) 1996-10-16
WO1995017883A1 (fr) 1995-07-06
US5653989A (en) 1997-08-05
DE4345186C2 (de) 1997-08-14
EP0737062B1 (de) 1998-05-06
JP3731607B2 (ja) 2006-01-05
DE4345186A1 (de) 1995-06-29
JPH09510692A (ja) 1997-10-28
DE69410119D1 (de) 1998-06-10
DE69410119T2 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
DE69410119D1 (de) Wasser-in-oel-lotion, die ein corticosteroid enthaelt
ES2131208T3 (es) Composiciones de limpieza personal.
ATE190224T1 (de) Tensidefreie wasser-in-öl emulsion
CA2117136A1 (en) Cosmetic applicator useful for cleansing, moisturizing and protecting the skin from diaper rash
FR2720941B1 (fr) Utilisation des sophorolipides et compositions cosmétiques et dermatologiques.
DE69628100D1 (de) Emulgierte Zusammensetzung des Wasser-in-Öl-Typs und Hautpflegemittel
BR9914925A (pt) Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero.
ES2161785T3 (es) Emplasto para el tratamiento de micosis ungulares.
CA2148652A1 (fr) Utilisation d'un antagoniste de substance p dans une composition cosmetique et composition obtenue
CA2269897A1 (fr) Derives d'aminophenol et leur utilisation en cosmetique
MX9301536A (es) Agente para regular la condicion grasosa de la piel.
CA2151422A1 (fr) Emulsion nettoyante huile-dans-eau ayant l'aspect d'un lait
ATE281152T1 (de) Verwendung von glycoglycerolipiden als tenside sowie kosmetische oder dermatologische zubereitungen, solche glycoglycerolipide enthaltend
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ES2084371T3 (es) Composiciones cosmeticas que contienen un extracto de eclipta alba.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
DE69302677D1 (de) Liposomale piroxycam formulierung
ATE210435T1 (de) Retinal enthaltendes arzneimittel
ES2123821T3 (es) Formulacion de pulverizacion que tiene un efecto refrescante.
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
DE69319589T2 (de) Juckreizstillendes mittel
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
ES2073286T3 (es) Productos cosmeticos estables.
ATE213621T1 (de) Kosmetische mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties